A Phase 2 Trial for Patients with Newly Diagnosed High Grade Glioma Treated with Concurrent Radiation Therapy, Temozolomide, and BMX-001

Grants and Contracts Details

StatusActive
Effective start/end date4/29/1912/31/24

Funding

  • BioMimetix JV LLC: $255,236.00